Viral Vectors and Plasmid DNA Manufacturing Market by Product Type (Viral Vectors (Retrovirus, Lentiviruses, Adenoviruses, Adeno-Associated Viruses, and Others) and Plasmid (DNA Conjugative Plasmids, and Non-Conjugative Plasmids)), by Application (Gene and Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, and Others), and by End-User (Biotechnology Companies, Research Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2026

Global viral vectors and plasmid DNA manufacturing market expected to generate revenue of around USD 1860 million by 2026, growing at a CAGR of around 20% between 2018 and 2026. The viral vectors and plasmid DNA manufacturing market is fragmented into product type, application, and end-user.

20-Dec-2018 | Number of pages: 120 | Report Code: ZMR-3664 | Report Format : | Status : Published

Abstract

The report covers a forecast and an analysis of the viral vectors and plasmid DNA manufacturing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the viral vectors and plasmid DNA manufacturing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the viral vectors and plasmid DNA manufacturing market on a global level.

In order to give the users of this report a comprehensive view of the viral vectors and plasmid DNA manufacturing market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Viral Vectors and Plasmid DNA Manufacturing Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the viral vectors and plasmid DNA manufacturing market by segmenting the market based on product type, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. By product type, the market is segmented into viral vectors and plasmid. The viral vectors are further segmented into a retrovirus, lentiviruses, adenoviruses, adeno-associated viruses, and others. The plasmid segment includes DNA conjugative plasmids and non-conjugative plasmids. By application, the market for viral vectors and plasmid DNA manufacturing is segmented into gene and cancer therapies, viral infections, immunotherapy, formulation development, and others. By end-user, the market is segmented into biotechnology companies, research institutes, hospitals, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further division into major countries including the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa. This segmentation includes the demand for viral vectors and plasmid DNA manufacturing market based on individual product type, application, and end-user in all the regions and countries.

The report also includes detailed profiles of various end players, such as Vigene Biosciences Inc., Lonza, FinVector Vision Therapies, Kaneka Corporation (Eurogentec), VGXI, Inc., VIROVEK, SIRION Biotech GmbH, Cobra Biologics, Novasep, FUJIFILM Diosynth Biotechnologies Inc., Spark Therapeutics, Inc., Genzyme Corporation, ALDEVRON, Brammer Bio, Oxford Gene Technology, and General Electric Company (GE Healthcare), among others.

This report segments the global viral vectors and plasmid DNA manufacturing market into:

Global Viral Vectors and Plasmid DNA Manufacturing Market: Product Type Analysis

  • Viral Vectors
    • Retrovirus
    • Lentiviruses
    • Adenoviruses
    • Adeno-Associated Viruses
    • Others
  • Plasmids
    • DNA Conjugative Plasmids
    • Non-Conjugative Plasmids

Global Viral Vectors and Plasmid DNA Manufacturing Market: Application Analysis

  • Gene and Cancer Therapies
  • Viral Infections
  • Immunotherapy 
  • Formulation Development
  • Others

Global Viral Vectors and Plasmid DNA Manufacturing Market: End-User Analysis

  • Biopharmaceutical Companies
  • Research Institutes
  • Others?

Global Viral Vectors and Plasmid DNA Manufacturing Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Animal Genetics Market by Product (Live Animals (Porcine, Poultry, Canine, Bovine, and Others) and Genetic Material (Embryo and Semen)) and by Service (Genetic Disease Tests, Genetic Trait Tests, DNA Typing, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Jan-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3718 | Report Format:

The report covers a forecast and an analysis of the animal genetics market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the animal ge...Read More

Primary Cells Market by Origin (Hematopoietic Cells, Renal Cells, Skin Cells, Lung Cells, Gastrointestinal Cells, Heart, Liver Cells, Skeletal and Muscle Cells, and Other Primary Cells), by Type (Human Primary Cells and Animal Primary Cells), and by End-User (Life Science Research Companies and Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Jan-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3689 | Report Format:

The report covers a forecast and an analysis of the primary cells market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the primary cells mark...Read More

Synthetic Stem Cell Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3620 | Report Format:

Global Synthetic Stem Cell Market: Overview Synthetic stem cells provide therapeutic benefits to its consumers andare able to reduce risks related to stem cell treatments. In addition to this, researchers have found that these cells possess better preservation stability and the technology is gen...Read More

Fill Finish Manufacturing Market by Product (Consumables (Vial, Prefilled Syringes, Cartridge, and Others) and Instruments) and by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, and Medical Device Companies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2024

Nov-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3559 | Report Format:

The report covers forecast and analysis for the fill finish manufacturing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Billion). The study includes drivers and restraints for the fill finish m...Read More

CRISPR Genome Editing Market by Applications (Genome Editing, Genetic Engineering, Gene Library, Human Stem Cells, and Other) and by End User (Biotechnology Companies, Pharmaceutical Companies, and Other): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Aug-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3307 | Report Format:

The report covers forecast and analysis for the CRISPR genome editing market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the CRISPR genome editing ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.